Individual Placement and Support: The Most Evidence-Based Employment Intervention in Mental Health
The Evidence Base
Individual Placement and Support (IPS) has the strongest evidence base of any employment intervention for people with mental health conditions. The core finding — that rapid placement in competitive employment with integrated clinical support produces far higher employment rates than traditional pre-vocational training and sheltered rehabilitation — has been replicated across 25+ randomised controlled trials in 15+ countries over 30 years.
The key numbers from the global evidence base:
- IPS employment rate: 55–62% achieve competitive employment in IPS programmes (meta-analysis range across 25 RCTs)
- Control/comparison employment rate: 20–28% in traditional vocational rehabilitation
- Relative risk: approximately 2.2–2.5 (people in IPS are 2.2–2.5× more likely to achieve employment than in traditional approaches)
- Number needed to treat: approximately 3–4 (for every 3–4 people enrolled in IPS instead of traditional rehabilitation, one additional person achieves employment)
The Cochrane systematic review (Kinoshita et al., 2013, updated 2022) — the gold standard of evidence synthesis — concluded that IPS is more effective than other approaches in helping people with severe mental illness gain and maintain competitive employment, with high-quality evidence.
What IPS Is
IPS is defined by eight fidelity principles, assessed through the IPS Fidelity Scale:
1. Zero exclusion: Any person who expresses interest in work is served — no exclusions based on diagnosis, substance use history, or previous work history
2. Competitive employment focus: The goal is ordinary jobs paying market wages, not sheltered work or volunteer positions
3. Integrated services: IPS employment specialists are embedded within clinical mental health teams, not separate
4. Attention to client preferences: Jobs are sought that match the individual's preferences, not predetermined by the programme
5. Benefits counselling: Every client receives individualised advice on how employment affects their benefits
6. Rapid job search: Job search begins quickly after enrolment — typically within 30 days — rather than after extended pre-vocational assessment
7. Systematic employer engagement: Employment specialists maintain ongoing relationships with employers, not one-off job placement
8. Time-unlimited support: Support continues as long as the client wants it, including after job placement
Programmes that implement all eight principles with high fidelity consistently achieve the employment rates described above. Programmes with low fidelity — particularly those that reintroduce eligibility criteria, prioritise sheltered work, or separate vocational and clinical teams — show substantially weaker outcomes.
European Evidence
The European evidence base for IPS has grown substantially since 2010:
EQOLISE Trial (6-country European RCT, Burns et al., 2007): The definitive European IPS trial. Across six sites (UK, Germany, Switzerland, Netherlands, Italy, Bulgaria), IPS participants achieved 55% employment vs 28% in standard vocational rehabilitation at 18 months. The Dutch and Swiss sites showed particularly strong results (60%+), while the Bulgarian site (where employer attitudes and labour market conditions were most challenging) showed the smallest effect.
Norwegian RCT (Sveinsdottir et al., 2014; PMC4611964): Conducted within Norway's high-benefit welfare system — one of the strongest tests of whether IPS can succeed where financial incentives to work are weakest. Result: 61% IPS vs 37% control at 12 months. The effect was maintained at 24 months. This is among the strongest effect sizes recorded for IPS anywhere.
Danish pilot evaluation (Aalborg University, 2022): Following the 2019 national rollout to three municipalities, early results show 45–55% employment rates among participants with severe mental illness — consistent with the international evidence.
UK IPS Implementation Study (NHS England, 2022): Following NHS Long Term Plan commitments, IPS has been embedded in Individual Placement and Support in Employment (IPSE) services across England. At 12 months, the NHS implementation achieves employment rates of 39–48% — somewhat below the RCT range, consistent with real-world implementation challenges (caseload pressures, variable fidelity, employer relations).
Netherlands (Radboud UMC, 2020): RCT comparing IPS to traditional day activities programmes. IPS: 52% competitive employment; comparison: 27%. Follow-up at 36 months showed sustained employment advantage.
Why European Implementation Lags the Evidence
Despite the evidence, IPS is not the standard of care across Europe. As of 2024:
- Systematic national implementation: UK (NHS England), Netherlands (partial), Norway (partial), Denmark (three municipalities expanded to national rollout in progress)
- Significant but fragmented: Germany (regional pilots), Sweden (Arbetsförmedlingen SE programme), Belgium (VDAB pilots in Flanders)
- Minimal or absent: Most of Eastern and Southern Europe
The barriers to implementation are well-documented:
Structural: IPS requires clinical and employment services to be co-located and integrated. In most European countries, mental health services (health ministry) and employment services (labour ministry) are in separate bureaucratic silos with different funding streams, performance metrics, and organisational cultures.
Financial: IPS employment specialists cost money during an investment period before employment outcomes materialise. Healthcare funders are reluctant to fund vocational services; employment funders are reluctant to fund clinical co-location.
Fidelity: As IPS scales, fidelity typically falls. The key fidelity elements most commonly compromised in European implementation are rapid job search (replaced by extended assessment) and zero exclusion (replaced by diagnostic or motivational screening).
Employer attitudes: IPS depends on employment specialists building relationships with employers willing to hire people disclosing mental health conditions. Stigma in the employer community — which varies significantly across European countries — is a real constraint on placement success.
The Economic Case
IPS is not only clinically superior to traditional rehabilitation — it is also more cost-effective.
A 2019 cost-effectiveness analysis by the London School of Economics (Knapp et al.) found that IPS produced employment at a cost of approximately £8,000–12,000 per quality-adjusted life year gained — well within standard NHS cost-effectiveness thresholds (£20,000–30,000/QALY). The analysis accounted for the costs of the programme and the benefits from reduced psychiatric hospitalisation, reduced benefit receipt, and increased tax contributions from employed participants.
The Norwegian IPS RCT included a health economic analysis (Sveinsdottir et al., 2020) that found IPS was cost-neutral from a societal perspective within 4 years of programme initiation — the increased employment revenue and reduced benefit expenditure offset the programme cost.
The Recommendation
The evidence is sufficiently strong to move from "promising intervention" to "should be the standard of care" for employment support for people with severe mental health conditions. This requires:
1. National policy mandates: IPS should be embedded in mental health legislation as a standard component of mental health care, as NHS England has done
2. Integrated funding streams: Joint health-employment funding for IPS employment specialists, removing the bureaucratic barrier to integration
3. Fidelity infrastructure: Independent fidelity review should be required for any programme using the IPS name — low-fidelity programmes produce significantly weaker outcomes and misrepresent the evidence base
4. Scale: The current European IPS caseload is a fraction of what a full implementation would serve. Norway, for example, has approximately 150 IPS places nationally; the eligible population is estimated at 15,000–20,000
The cost of inaction is measurable: for every 1,000 people who receive traditional rehabilitation instead of IPS, approximately 300–350 additional people fail to achieve employment who would have done so with IPS. At average European wage levels, this represents approximately €15–20 million in foregone annual earnings and €6–9 million in foregone tax revenues — per 1,000 people, per year.
Sources: Kinoshita et al., Cochrane Database 2013 (updated 2022); Burns et al., Lancet 2007 (EQOLISE); Sveinsdottir et al., BMC Psychiatry 2014; Radboud UMC 2020; NHS England IPSE Data 2022; Knapp et al., LSE 2019; Aalborg University 2022; Drake & Bond, Psychiatric Services 2021.